Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.5900
+0.0072 (1.24%)
Jun 23, 2026, 10:55 AM EDT - Market open
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,571
Profits / Employee
-$1,361,417
Market Cap
14.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| BioLineRx | 24 |
| OSR Holdings | 22 |
| Jasper Therapeutics | 22 |
| IN8bio | 17 |
| SeaStar Medical Holding | 17 |
| BioVie | 13 |
| Cocrystal Pharma | 10 |
LEXX News
- 1 hour ago - Lexaria's Animal Study GLP-1-A26-1 has Begun Dosing on Schedule - TheNewswire
- 6 days ago - Lexaria Bioscience provides update on GLP-1 oral pill market - TheFly
- 6 days ago - GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand - Accesswire
- 6 days ago - GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand - TheNewswire
- 14 days ago - Lexaria announces dosing completion in 2026 Animal Study 2 - TheFly
- 14 days ago - Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway. - TheNewswire
- 14 days ago - Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway - Accesswire
- 20 days ago - Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program - Accesswire